RAINIER Trial Data Update: Two Additional AML Patients Achieve Remission Within 30 Days of Treatment

March 20, 2025 8:35 AM

Across two trials, 9 of 10 frontline AML patients achieved remission when treated with mipletamig in combination with the standard of careTriplet Combination with mipletamig continues to outperform doublet combination benchmarkNo Cytokine Release Syndrome (CRS) has been observed in the RAINIER trial to dateCohort 2 enrollment nears completionSEATTLE, WA / ACCESS Newswire / March 20, 2025 / Aptevo Therapeutics ("Aptevo") (NASDAQ:APVO), a...

Read more

Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin

March 20, 2025 8:30 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent pending drug delivery technology, today announced that it its contract manufacturer, Glatt Air Techniques, Inc., part of Glatt Group, a vertically integrated pharmaceutical services company with FDA- and EU-approved sites, has completed its first Good Manufacturing Practice ("GMP") Clinical Batch of its pharmaceutical-grade oral...

Read more

Nose Surgeon Discusses How Rhinoplasty Goals Vary Based on Facial Balance and Structural Needs

March 20, 2025 8:00 AM

Choosing to undergo rhinoplasty, or surgery to reshape the nose, can be a significant decision for individuals who wish to improve both facial harmony and nasal function. A carefully planned rhinoplasty should address not only aesthetic goals but also the unique structural needs of each patient. In Princeton, Dr. Alisa Yamasaki, a facial plastic surgeon at Yamasaki Facial Plastic Surgery, underscores the importance of a personalized approach,...

Read more

Vheda Health Launches 2025 Educational Series for Health Plans Focused on Engagement, Medical Cost Savings, and Improved Health Outcomes

March 20, 2025 8:00 AM

Vheda Health, a nationally certified Minority Business and leader in virtual health engagement, is proud to announce the launch of a 6-Part Educational Series designed for Medicaid, Medicare, and SNP health plans. This series will provide real-world case studies, combined with proven playbooks health insurers can use that increases engagement, lowers medical cost, and improves quality scores, creating health equity for all.The series will be...

Read more

Kiffik Biomedical and Rubix LS Partner to Revolutionize Cancer Diagnostics With Interstitial Fluid and Aptamer Technologies

March 20, 2025 8:00 AM

Kiffik Biomedical, a leader in interstitial fluid (ISF)-based diagnostics, has announced a strategic partnership with Rubix LS, a pioneer in aptamer-based precision medicine, to develop a first-of-its-kind rapid colorectal cancer test. This collaboration combines KIFFIK's groundbreaking ISF biomarker collection technology with Rubix LS's advanced aptamer detection platform, offering an innovative, non-invasive alternative to traditional...

Read more

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread

March 20, 2025 7:00 AM

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations work to ensure that any and all information contained within is true and accurate as of the date hereof to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice. Click here...

Read more

Katie Zippel Announces Groundbreaking Research on Social Prescribing in 2025

March 20, 2025 3:40 AM

Dr. Katie Zippel, a distinguished general practitioner and DPhil candidate at Oxford University, has unveiled pioneering research on social prescribing and its impact on individuals living with cancer. Her latest study, which will be published in a leading peer-reviewed journal, provides compelling evidence on the role of non-medical interventions in enhancing patient well-being and long-term health outcomes. As both a medical professional and a...

Read more

Nomination Committee's Proposal for a New Chairman and Composition of Spago Nanomedical’s Board

March 20, 2025 3:20 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today that the company's nomination committee proposes a changed board composition to meet the needs of the company's current stage. For the 2025 Annual General Meeting, the nomination committee proposes the election of current board member Alan Raffensperger as the new chairman of the board and the election of oncologist Dr. Mikael von Euler as a new board member....

Read more

IROA Technologies Showcases Groundbreaking Nature Publication With Bioz Integration

March 20, 2025 3:00 AM

Bioz, Inc., the leader in AI-powered scientific product validation, is excited to announce a new collaboration with IROA Technologies, a pioneer in metabolomics solutions. This partnership highlights the recent Nature Communications publication, Ion Suppression Correction and Normalization for Non-Targeted Metabolomics, published on January 27, 2025, which features IROA's TruQuant Workflow as a key innovation in the field.With the integration of...

Read more

Alpha Genesis Whistleblower Documents Exposed as Fabricated Misinformation

March 19, 2025 5:00 PM

Recent claims made in so-called "whistleblower" documents regarding Alpha Genesis, Inc. have been thoroughly examined and found to be fraudulent. These documents are part of a deliberate misinformation campaign aimed at discrediting a well-respected research institution known for its commitment to ethical practices, scientific integrity, and regulatory compliance. The reckless dissemination of these falsehoods not only misleads the public but...

Read more

Bionic Bloom Expands Integrative Psychiatry Team

March 19, 2025 4:25 PM

Bionic Bloom, the nation's first legal psilocybin therapy center and a leader in integrative mental health, proudly welcomes Arielle Bernhardt, MSN, APRN, to its team of pioneering practitioners. Arielle brings a wealth of expertise in psychiatric nursing, blending traditional medication management with holistic, patient-centered care. With a background in adult-gerontology and extensive experience in acute psychiatry, addiction treatment, and...

Read more

College Football’s Quay'Sheed Scott Teams Up With ZetrOZ Systems as sam Brand Ambassador

March 19, 2025 2:15 PM

Quay'sheed Scott had an impressive year as a freshman defensive back for the University of Kentucky Wildcats, playing 11 games even as he worked through injuries. One key to his season: SAM Recover, the ultrasound treatment with sam® (sustained acoustic medicine) system developed by ZetrOZ Systems.Scott is the latest high-level competitive athlete to sign on as a sam® Brand Ambassador, spreading the word about the benefits of using the sam®...

Read more

TruMerit and International Council of Nurses Launch Collaborative to Propel Nursing Workforce Development Worldwide

March 19, 2025 12:00 PM

TruMerit™ (formerly CGFNS International) and the International Council of Nurses (ICN) have announced the launch of a jointly operated clearinghouse for research, data, and policy solutions on the world's nursing workforce.The new collaborative, the Global Nursing Workforce Centre, will address the absence of a central repository to aggregate and analyze this knowledge and highlight gaps. It will mobilize evidence-driven capacity building...

Read more

Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes

March 19, 2025 11:45 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that it has launched an offering (the "Offering") of $4.0 billion aggregate principal amount of new senior secured notes due 2032 (the "Notes") through its indirect wholly-owned subsidiary, 1261229 B.C. Ltd., a company incorporated under the laws of British Columbia, Canada (the "Issuer") that, at the closing of the transactions will be a...

Read more

Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities

March 19, 2025 11:45 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that it has launched the syndication of new senior secured credit facilities totaling at least $3.8 billion.The new senior secured credit facilities are expected to consist of (i) a 5-year senior secured revolving credit facility in an amount of at least $400 million (the "New Revolving Facility") and (ii) a $3,400 million 5.5-year secured term...

Read more

IKS Health Achieves #1 Rankings in 2025 Black Book Key Metrics for Clinical Documentation, Virtual Medical Scribes & Transcription Solutions, and Medical Coding

March 19, 2025 9:00 AM

Black Book™, a global leader in independent healthcare market research, announced the results of its 2025 HIM Services User Survey, identifying IKS Health achieving #1 client ratings in 2025 Black Book Key Metrics for Clinical Documentation, Virtual Medical Scribes & Transcription Solutions, and Medical Coding. Based on feedback from over 1,100 validated healthcare professionals, IKS Health earned top rankings in critical operational and service...

Read more

Dr. Bustillo Discusses the Deep Plane Facelift and Why Surgeon Expertise Matters More Than Ever

March 19, 2025 9:00 AM

As interest in facial rejuvenation continues to rise, one of the most advanced techniques-the deep plane facelift-is gaining attention for its ability to deliver more natural and longer-lasting results. However, due to the complexity of this procedure, the expertise of the surgeon is more crucial than ever. Dr. Andres Bustillo, a board-certified facial plastic surgeon based in Miami, highlights the importance of selecting a qualified and...

Read more

UniDoc Announces Purchase Agreement for AGNES Connect Software from AMD Telemedicine

March 19, 2025 9:00 AM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), an innovator in the eHealth sector, is pleased to announce it has entered into a definitive purchase agreement (the "Agreement") for the acquisition of the AGNES Connect software from AMD Telemedicine ("AMD"). This software forms the foundation of UniDoc's previously announced NEIL Connect software platform.Highlights of proposed acquisition of AGNES...

Read more

AI-Driven Digital Pathology Poised for Breakthrough Adoption in Hospitals: Black Book Research Identifies Market Leaders

March 19, 2025 8:30 AM

Black Book Research has added digital pathology to its market competitive intelligence responding to the increasing demand from both buyers and vendors for independent, unbiased evaluations of this rapidly evolving technology. As healthcare organizations seek data-driven diagnostics, the surge in digital pathology adoption has positioned it as a critical area of investment and transformation. With a compound annual growth rate (CAGR) projected...

Read more

Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells

March 19, 2025 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), a leader in age-reversal science, today announced groundbreaking preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate cancer animal model using highly aggressive human prostate cancer cells. It was found that Telomir-1 actively suppresses cancer growth rather than promoting it, and protects against chemotherapy-induced toxicity and...

Read more